Singapur - angleščina - HSA (Health Sciences Authority)

johnson & johnson international (singapore) pte ltd - ustekinumab - injection, solution - 45mg/vial - ustekinumab 45mg/vial

Singapur - angleščina - HSA (Health Sciences Authority)

johnson & johnson pte. ltd. - ustekinumab - injection, solution - 90mg/vial - ustekinumab 90mg/vial

Singapur - angleščina - HSA (Health Sciences Authority)

johnson & johnson international (singapore) pte ltd - ustekinumab - injection, solution - 45mg/0.5ml - ustekinumab 45mg/0.5ml

Singapur - angleščina - HSA (Health Sciences Authority)

johnson & johnson international (singapore) pte ltd - ustekinumab - injection, solution - 90mg/1ml - ustekinumab 90mg/1ml

Filipini - angleščina - FDA (Food And Drug Administration)

pedia aid, inc. - bcg vaccine - freeze-dried powder for injection (id) - 500 mcg/ml

Kanada - angleščina - Health Canada

connaught laboratories ltd. - bacillus calmette-guerin bcg - powder for solution - 27mg - bacillus calmette-guerin bcg 27mg - antineoplastic agents

Kanada - angleščina - Health Canada

merck canada inc - bacillus calmette-guerin (bcg) strain tice - powder for solution - 800000000unit - bacillus calmette-guerin (bcg) strain tice 800000000unit - vaccines

Avstralija - angleščina - Department of Health (Therapeutic Goods Administration)

janssen-cilag pty ltd - ustekinumab, quantity: 45 mg - injection, solution - excipient ingredients: water for injections; sucrose; polysorbate 80; histidine; histidine hydrochloride monohydrate - plaque psoriasis,adults - stelara is indicated for the treatment of adult patients (18 years or older) with moderate to severe plaque psoriasis who are candidates for phototherapy or systemic therapy.,paediatric population, 6 years and older - stelara is indicated for the treatment of moderate to severe plaque psoriasis in children and adolescent patients from 6 years of age who are inadequately controlled by, or are intolerant to, other systemic therapies or phototherapies.,psoriatic arthritis (psa),stelara, alone or in combination with methotrexate, is indicated for the treatment of signs and symptoms of active psoriatic arthritis in adult patients (18 years and older) where response to previous non-biological dmard therapy has been inadequate.,crohn?s disease,stelara is indicated for the treatment of adult patients with moderately to severely active crohn?s disease who have had an inadequate response, lost response, or were intolerant to either conventional therapy or a tnf alpha antagonist or have medical contraindications to such therapies.,ulcerative colitis,stelara is indicated for the treatment of adult patients with moderately to severely active ulcerative colitis.

Avstralija - angleščina - Department of Health (Therapeutic Goods Administration)

pfizer australia pty ltd - temsirolimus, quantity: 30 mg - injection, solution - excipient ingredients: polysorbate 80; macrogol 400; ethanol absolute - temsirolimus is indicated for the treatment of advanced renal cell carcinoma.,torisel is indicated for the treatment of advanced renal cell carcinoma. torisel is indicated for treatment of patients with relapsed and/or refractory mantle cell lymphoma.

Armenija - angleščina - Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

glaxosmithkline biologicals s.a. - poliovirus types 1, poliovirus types 3 - suspension oral - not less than-106ccid50/dose+ not less than-105.8ccid50/dose